- Home
- » Tags
- » Bioequivalence
Top View
- Influence of Gastrointestinal Disorders and Surgery on Oral Drug Performance Grace B. Hatton1, Christine M. Madla1, Sarit C. Rabbie1, Abdul W. Basit1
- Buchanan Ingersoll 1.\\ Rooney PC
- Current Challenges and Future Perspectives in Oral Absorption
- Revised EMA Bioequivalence Guideline
- Levothyroxine for Hypothyroidism
- Bioequivalence and Bioavailability Clinical Trials: a Status Report from the National Institutes of Health Clinicaltrials.Gov Registry
- Pharmacometric Approach to Define Narrow Therapeutic Index (NTI) Drugs & Evaluate Bioequivalence (BE) Criteria for NTI
- Antimicrobial Resistance: What Does Medicine Quality Have to Do with It?
- Bioequivalence & Bioavailability of Receptors Dopamine
- Guideline on the Use of Pharmacogenetic Methodologies in the Pharmacokinetic Evaluation of Medicinal Products
- INTEGRATED TOXICOLOGY (3Rs in ACTION) and HOW in VITRO TOXICOLOGY IS CRITICAL for SUCCESS for a DERMAL IND
- Effective Bioequivalence Research System As an Important Tool of Affordable and Good Quality Medicines in Ukraine
- Current Challenges and Future Perspectives in Oral Absorption Research: an Opinion of the UNGAP Network
- Predictors of Tacrolimus Pharmacokinetic Variability: Current Evidences and Future Perspectives
- FDA Guidance for Industry on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products C General Considerations
- Current Challenges and Future Perspectives in Oral Absorption Research: an Opinion of the UNGAP Network
- A Phase 1 Study to Evaluate the Bioequivalence of Oral Tablet and Orally Dissolving Tablet Formulations of Rimegepant, a Small M
- BD1412-62CEC Bioequivalence and Secondarily Drug-Drug Interaction Of
- NATIONAL ACTION PLAN on COMBATTING DRUG RESISTANCE in the Period from 2013 - 2020
- Basic Pharmacokinetics Sample Chapter
- PEARRL Review-Dr N Fotaki
- Study Protocol Number MS 200585-0002
- Food-Effect Bioavailability and Fed Bioequivalence Studies
- Bioequivalence of Medicines
- Guideline on the Investigation of Bioequivalence
- Bioavailability and Bioequivalence Studies
- Basic Concepts in Pharmacokinetics
- Draft Policy on Antimicrobial Use and Resistance
- Pharmacokinetics and Bioequivalence of Two Different 20 Mg Olmesartan Tablets
- Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations
- Bioavailability and Bioequivalence Pharmaceutical R&D Summit September 29-October 01, 2014 Doubletree by Hilton Baltimore-BWI Airport, USA
- Use of Pharmacogenetics in Bioequivalence Studies to Reduce Sample Size: an Example with Mirtazapine and CYP2D6
- Blood Level Bioequivalence Study Vich Gl52
- Sampling Times and Genotyping Concerns in Bioequivalence Evaluation of Branded and Generic Formulations
- Protocol I4V-MC-JAGU a Bioequivalence and Food Effect Study in Healthy Subjects Comparing Baricitinib Suspension and Commercial Tablet Formulations
- Guidance for Industry
- 186 PART 320—BIOAVAILABILITY and BIOEQUIVALENCE REQUIREMENTS Subpart A—General Provisions
- Kivexa, INN-Abacavir/Lamivudine
- (Cpmp) Note for Guidance on the Investigation of Bioavailability and Bioequivalence
- Guideline on Equivalence Studies for the Demonstration of Therapeutic Equivalence for Locally Applied, Locally Acting Products in the Gastrointestinal Tract†
- Bioequivalence Study of Two Valsartan 160 Mg Formulations: an Open-Label, Randomised-Sequence, Single-Dose, Two-Way Crossover St
- Advancing Quality of Medicines to Combat Antimicrobial Resistance Advancing Quality of Medicines to Combat Antimicrobial Resistance
- Guideline for Bioequivalence Studies for Different Strengths of Oral Solid Dosage Forms
- STATISTICAL ANALYSIS of PHARMACOKINETIC DATA--- BIOEQUIVALENCE STUDY by Qingmin Guo a THESIS Submitted to Michigan State Univers
- A Primer on Generic Drugs and Bioequivalence
- Food and Drug Administration, HHS § 320.33